0
Poster Presentations: Wednesday, November 3, 2010 |

Intra-Lymph Node Depot Methylprednisolone Injection in Residual Tuberculous Lymph Nodes FREE TO VIEW

Gupta Rakesh, MD; Ankur Gupta, MBBS; George Jacob, MBBS; A. R. Paramez, MD
Author and Funding Information

JLN Medical College, AJMER, India



Chest. 2010;138(4_MeetingAbstracts):676A. doi:10.1378/chest.10170
Text Size: A A A
Published online

Abstract

PURPOSE: Tuberculous lymphadenitis (TBLN) is the most common type of extra pulmonary TB in India which is managed with 2 (HRZE) 3 /4HR under RNTCP. In 60% cases, residual lymph nodes are present after completion of 6 months chemotherapy and associated with cold abscess formation and anxiety to patients.Intra lymph node depot methyl prednisolone has strong anti inflammatory property & suppresses TNF α leading to rapid regression in TBLN size.

METHODS: Patients having residual lymph nodes (Res TBLN) after adequate anti TB treatment were enrolled in this study. The number, size, consistency, mobility, and matting were recorded. Patients with cold abscess, diabetes mellitus, HIV, chronic renal failure were excluded.1-2 ml of Inj. Methyl prednisolone acetate (depot) (DMPA) was injected fortnightly into the lymph nodes, depending on the size of lymph nodes.(max thrice). Patients were followed up fortnightly for response and complications. Successful outcome was considered when reduction of more than 50% in size at end of 6 week was achieved. INH & EMB combination was used during DMPA therapy. Every alternate patient was put on same chemotherapy to serve as controls without I/L DMPA.

RESULTS: Out of the 334 patients studied, ≥50% reduction in size was noted in 151 patients (45.20%) in 2 weeks, in 265 patients (79.34%) in 4 weeks, 301 patients (90.11%) in 6 weeks. In control cases, 15% patients had significant reduction in size after completion of 6 weeks additional INH + EMB treatmentComplications observed in the study were transient pain at injection site (8%) unilateral chest pain, and pain radiating to arm. Cold abscess, sinus formation, extension of lesion, was not observed.

CONCLUSION: Intra lymph node Inj. Methyl Prednisolone Acetate (depot) accelerates the reduction of size of tuberculous lymph nodes, without causing systemic or local side effects when given with INH +EMB cover.

CLINICAL IMPLICATIONS: Intra lymph node Inj. Methyl Prednisolone Acetate (depot) accelerates the reduction of size of tuberculous lymph nodes, without causing systemic or local side effects when given with INH +EMB cover.

DISCLOSURE: GUPTA RAKESH, No Financial Disclosure Information; No Product/Research Disclosure Information

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543